Dentsply Sirona Reports Third Quarter 2024 Results

CHARLOTTE, N.C. , Nov. 07, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ( Dentsply Sirona or the "Company") (Nasdaq: XRAY) today announced its financial results for the third …

CouponFollow Extension

86%
OFF

DENTSPLY SIRONA ( NASDAQ:XRAY ) Third Quarter 2024 Results

3 weeks from now

Nov 9, 2024 · DENTSPLY SIRONA (NASDAQ:XRAY) Third Quarter 2024 ResultsKey Financial Results. Revenue: US$951.0m (flat on 3Q 2023). Net loss: US$494.0m (loss widened by 86% …

yahoo.com

5%
OFF

Dentsply Sirona : Reports Third Quarter 2024 Results (dentsply …

3 weeks from now

Nov 7, 2024 · Dentsply Sirona Reports Third Quarter 2024 Results November 7, 2024 Net sales of $951 million increased 0.5%, organic sales increased 1.3% ...

marketscreener.com

05%
OFF

DENTSPLY SIRONA Q3 2024 Earnings Report - MarketBeat

3 weeks from now

Nov 7, 2024 · DENTSPLY SIRONA Q3 2024 Earnings Report $19.62 +0.01 (+0.05%) As of 01/28/2025 04:00 PM Eastern ... operator, and good morning, everyone. Welcome to the …

marketbeat.com

5%
OFF

Dentsply Sirona Reports Mixed Q3 2024 Results - Markets Insider

3 weeks from now

Nov 8, 2024 · In the third quarter of 2024, Dentsply Sirona reported net sales of $951 million, marking a slight increase of 0.5% from the previous year, with organic sales growth of 1.3%.

businessinsider.com

$0.50
OFF

DENTSPLY SIRONA (XRAY) Earnings Date And Reports 2025

3 weeks from now

3 days ago · DENTSPLY SIRONA issued Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.50, which topped the consensus estimate of $0.48 by $0.02. Quarterly revenue …

marketbeat.com

5%
OFF

Dentsply Sirona Reports Third Quarter 2024 Results

3 weeks from now

Nov 7, 2024 · dentsply sirona inc xray: dentsply sirona reports third quarter 2024 results. dentsply sirona: qtrly net sales of $951 million increased 0.5%. dentsply sirona inc: revised outlook fy …

tradingview.com

$0.50
OFF

Dentsply Sirona Q3 Adjusted Earnings, Revenue Increase; 2024 …

3 weeks from now

Nov 7, 2024 · -- Dentsply Sirona reported Q3 adjusted earnings Thursday of $0.50 per diluted share, up from $0.49 a year earlier. ... DENTSPLY SIRONA Inc. Reports Earnings Results for …

marketscreener.com

5%
OFF

Dentsply Sirona Reports Third Quarter 2024 Results

3 weeks from now

Nov 7, 2024 · Net sales of $951 million increased 0.5%, organic sales increased 1.3%GAAP gross margin of 52.1%, GAAP net loss of million or loss per share of Adjusted EBITDA margin …

marketscreener.com

5%
OFF

Dentsply Sirona Reports Third Quarter 2024 Results

3 weeks from now

Nov 7, 2024 · Dentsply Sirona (XRAY) reported Q3 2024 results with net sales of $951 million, up 0.5% year-over-year, with organic sales growth of 1.3%.The company posted a GAAP net loss …

stocktitan.net

5%
OFF

Dentsply Sirona Reports Third Quarter 2024 Results

3 weeks from now

Nov 7, 2024 · Dentsply Sirona Reports Third Quarter 2024 Results • Net sales of $951 million increased 0.5%, organic sales increased 1.3% • GAAP gross margin of 52.1%, GAAP net loss …

dentsplysirona.com

5%
OFF

Dentsply Sirona : Reports Third Quarter 2024 Results Form 8 K

3 weeks from now

Nov 7, 2024 · Dentsply Sirona Reports Third Quarter 2024 Results •Net sales of $951 million increased 0.5%, organic sales increased 1.3% •GAAP gross margin of 52.1%, GAAP net...

marketscreener.com

2%
OFF

Full Year And Fourth Quarter 2024 Earnings Results - Goldman …

3 weeks from now

Goldman Sachs Reports Full Year and Fourth Quarter 2024 Earnings Results Operating Expenses Full Year Operating expenses were $33.77 billion for 2024, 2% lower than 2023. …

goldmansachs.com

27%
OFF

The Cigna Group Reports Fourth Quarter And Full Year 2024 …

3 weeks from now

3 days ago · Total revenues for 2024 increased 27% to $247.1 billion Shareholders' net income for 2024 was $3.4 billion, or $12.12 per share Adjusted income from...

prnewswire.com

5%
OFF

Dentsply Sirona Reports Third Quarter 2024 Results - GuruFocus

3 weeks from now

Nov 7, 2024 · Net sales of $951 million increased 0.5%, organic sales increased 1.3%GAAP gross margin of 52.1%, GAAP net loss of ($494) million or loss per share of ($2.46)Ad

gurufocus.com

FAQs about Dentsply Sirona Reports Third Quarter 2024 Results Coupon?

How did Dentsply Sirona perform in the third quarter of 2024?

CHARLOTTE, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2024. Third quarter net sales of $951 million increased 0.5% (organic sales increased 1.3%) compared to the third quarter of 2023. ...

What time does Dentsply Sirona hold a conference call?

CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 27, 2025, at 8:30 am ET to review its fourth quarter and full year 2024 financial results. ...

What percentage of Dentsply Sirona implants are essential?

37% Essential… 18% Implants… 16% Equipme… 14% CAD/ CAM 8% Orthodo… 7% Wellspec… 2024 Dentsply Sirona. All Rights Reserved. The Investor Relations website contains information about Dentsply Sirona's business for stockholders, potential investors, and financial analysts. ...

When is Dentsply Sirona's investor conference call & live webcast?

Conference Call/Webcast Information Dentsply Sirona’s management team will host an investor conference call and live webcast on November 7, 2024, at 8:30 am ET. ...

Where is Dentsply Sirona located?

Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. ...

Who is Dentsply Sirona?

Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. ...